Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: CISPLATIN, . Treffer: 139

2025

Miguel, S; Ortín-Fernández, J; Gómez-Pastor, S; Moliné, MÁ; Sánchez-Murcia, PA; Corral, I; Sanz-Rodríguez, F; González-Vadillo, AM Reimagining Pt(II) Anticancer Agents: The Role of Ferrocene in Monofunctional Chemotherapeutic Compounds.
Inorg Chem. 2025; Doi: 10.1021/acs.inorgchem.5c00704 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Moik, F; Terbuch, A; Sprakel, A; Pichler, G; Barth, DA; Pichler, R; Rainer, P; Silbernagel, G; Mannweiler, S; Jost, PJ; Ahyai, SA; Bauernhofer, T; Hutterer, GC; Pichler, M Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortality.
J Thromb Haemost. 2025; Doi: 10.1016/j.jtha.2025.01.022
PubMed FullText FullText_MUG

 

Oflaz, FE; Bondarenko, AI; Trenker, M; Waldeck-Weiermair, M; Gottschalk, B; Bernhart, E; Koshenov, Z; Radulović, S; Rost, R; Hirtl, M; Pilic, J; Karunanithi, Nivedita, A; Sagintayev, A; Leitinger, G; Brachvogel, B; Summerauer, S; Shoshan-Barmatz, V; Malli, R; Graier, WF Annexin A5 controls VDAC1-dependent mitochondrial Ca2+ homeostasis and determines cellular susceptibility to apoptosis.
EMBO J. 2025; Doi: 10.1038/s44318-025-00454-9 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Rousseau, B; Patel, M; Artz, O; Vlachos, G; Patel, S; Hayatt, O; Argilés, G; Foote, MB; Luo, L; Shah, R; Mehta, S; Rangavajhula, K; Stewart, CM; Gerber, D; Bhattacharya, R; Stephens, D; Mieles, D; Randrian, V; Abdelfattah, S; Zhang, L; Membreno-Berganza, N; Lamendola-Essel, MF; Piastra-Facon, F; Vidal, J; Johannet, P; Lu, S; White, JR; Maron, SB; Barlas, A; Weipert, CM; Rosiek, E; Zhang, T; He, B; Monette, S; Qu, R; Fidele, D; Bowker, S; Kahn, A; Vitiello, PP; Germano, G; Bardelli, A; Mandal, R; Ma, X; Chan, TA; Lu, S; Cercek, A; Abdel-Wahab, O; de, Stanchina, E; Segal, NH; Diaz, LA Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer.
Cancer Cell. 2025; Doi: 10.1016/j.ccell.2025.05.010
PubMed FullText FullText_MUG

 

2024

Hecht, M; Frey, B; Gaipl, US; Tianyu, X; Eckstein, M; Donaubauer, AJ; Klautke, G; Illmer, T; Fleischmann, M; Laban, S; Hautmann, MG; Tamaskovics, B; Brunner, TB; Becker, I; Zhou, JG; Hartmann, A; Fietkau, R; Iro, H; Döllinger, M; Gostian, AO; Kist, AM Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma - knowledge obtained from the CheckRad-CD8 trial.
Neoplasia. 2024; 49:100953 Doi: 10.1016/j.neo.2023.100953 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Liang, X; Liu, H; Hu, H; Ha, E; Zhou, J; Abedini, A; Sanchez-Navarro, A; Klötzer, KA; Susztak, K TET2 germline variants promote kidney disease by impairing DNA repair and activating cytosolic nucleotide sensors.
Nat Commun. 2024; 15(1): 9621 Doi: 10.1038/s41467-024-53798-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Lorusso, D; Xiang, Y; Hasegawa, K; Scambia, G; Leiva, M; Ramos-Elias, P; Acevedo, A; Cvek, J; Randall, L; Pereira, de, Santana, Gomes, AJ; Contreras, Mejía, F; Helpman, L; Akıllı, H; Lee, JY; Saevets, V; Zagouri, F; Gilbert, L; Sehouli, J; Tharavichitkul, E; Lindemann, K; Colombo, N; Chang, CL; Bednarikova, M; Zhu, H; Oaknin, A; Christiaens, M; Petru, E; Usami, T; Liu, P; Yamada, K; Toker, S; Keefe, SM; Pignata, S; Duska, LR, , ENGOT-cx11/GOG-3047/KEYNOTE-A18, investigators Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet. 2024; Doi: 10.1016/S0140-6736(24)01808-7
Web of Science PubMed FullText FullText_MUG

 

2023

Cyran, AM; Kleinegger, F; Nass, N; Naumann, M; Haybaeck, J; Arens, C Inhibition of EIF2α Dephosphorylation Decreases Cell Viability and Synergizes with Standard-of-Care Chemotherapeutics in Head and Neck Squamous Cell Carcinoma.
Cancers (Basel). 2023; 15(22): Doi: 10.3390/cancers15225350 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Taghizadeh, H; Djanani, A; Eisterer, W; Gerger, A; Gruenberger, B; Gruenberger, T; Rumpold, H; Weiss, L; Winder, T; Wöll, E; Prager, GW Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma - an Austrian expert consensus statement.
Front Oncol. 2023; 13:1225154 Doi: 10.3389/fonc.2023.1225154 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Terbuch, A; Walser, G; Stotz, M; Gerger, A; Posch, F; Bauernhofer, T Primary Thromboprophylaxis and the Risk of Venous Thromboembolic Events in Patients With Testicular Germ Cell Tumors Treated With Cisplatinum-Based Chemotherapy.
Clin Genitourin Cancer. 2023; 21(1):24-31 Doi: 10.1016/j.clgc.2022.10.005
Web of Science PubMed FullText FullText_MUG

 

Wyrich, M; Ohlig, H; Wessolly, M; Mairinger, E; Steinborn, J; Brcic, L; Hegedus, B; Hager, T; Greimelmaier, K; Wohlschlaeger, J; Mairinger, FD; Borchert, S Induction of metallothionein expression by supplementation of zinc induces resistance against platinum-based treatment in malignant pleural mesothelioma
TRANSL CANCER RES. 2023; Doi: 10.21037/tcr-22-2651 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2022

Dieckmann, KP; Pokrivcak, T; Geczi, L; Niehaus, D; Dralle-Filiz, I; Matthies, C; Dienes, T; Zschabitz, S; Paffenholz, P; Gschliesser, T; Pichler, R; Mego, M; Bader, P; Zengerling, F; Heinzelbecker, J; Krausewitz, P; Krege, S; Aurilio, G; Aksoy, C; Hentrich, M; Seidel, C; Torzsok, P; Nestler, T; Majewski, M; Hiester, A; Buchler, T; Vallet, S; Studentova, H; Schonburg, S; Niedersuss-Beke, D; Ring, J; Trenti, E; Heidenreich, A; Wulfing, C; Isbarn, H; Pichlmeier, U; Pichler, M Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study
THER ADV MED ONCOL. 2022; 14: 17588359221086813 Doi: 10.1177/17588359221086813 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hecht, M; Eckstein, M; Rutzner, S; von, der, Grün, J; Illmer, T; Klautke, G; Laban, S; Hautmann, MG; Brunner, TB; Tamaskovics, B; Hinke, A; Zhou, JG; Frey, B; Donaubauer, AJ; Becker, I; Semrau, S; Hartmann, A; Balermpas, P; Budach, W; Gaipl, US; Iro, H; Gostian, AO; Fietkau, R Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer.
J Immunother Cancer. 2022; 10(1): Doi: 10.1136/jitc-2021-003747 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Klingseisen, V; Slanovc, J; Regouc, M; Hrzenjak, A Bisdemethoxycurcumin sensitizes the response of cisplatin resistant non-small cell lung carcinoma cell lines by activating apoptosis and autophagy
J NUTR BIOCHEM. 2022; 106: 109003 Doi: 10.1016/j.jnutbio.2022.109003
Web of Science PubMed FullText FullText_MUG

 

Koll, FJ; Schwarz, A; Köllermann, J; Banek, S; Kluth, L; Wittler, C; Bankov, K; Döring, C; Becker, N; Chun, FKH; Wild, PJ; Reis, H CK5/6 and GATA3 Defined Phenotypes of Muscle-Invasive Bladder Cancer: Impact in Adjuvant Chemotherapy and Molecular Subtyping of Negative Cases.
Front Med (Lausanne). 2022; 9: 875142 Doi: 10.3389/fmed.2022.875142 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Mathilakathu, A; Wessolly, M; Mairinger, E; Uebner, H; Kreidt, D; Brcic, L; Steinborn, J; Greimelmaier, K; Wohlschlaeger, J; Schmid, KW; Mairinger, FD; Borchert, S Cancer-Associated Fibroblasts Regulate Kinase Activity in Mesothelioma Cell Lines via Paracrine Signaling and Thereby Dictate Cell Faith and Behavior.
Int J Mol Sci. 2022; 23(6): Doi: 10.3390/ijms23063278 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Terbuch, A; Posch, F; Bauernhofer, T; Jost, PJ; Partl, R; Stranzl-Lawatsch, H; Baciarello, G; Fizazi, K; Giannatempo, P; Verzoni, E; Sweeney, C; Ravi, P; Tran, B; Basso, U; White, J; Vincenzi, B; Oing, C; Cutuli, HJ; Dieckmann, KP; Gamulin, M; Chovanec, M; Fankhauser, CD; Heidenreich, A; Mohamad, O; Thibault, C; Fischer, S; Gillessen, S, , International, Germ, Cell, Cancer, Collaborative, Group Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2022; 113(4):825-832 Doi: 10.1016/j.ijrobp.2022.03.021
Web of Science PubMed FullText FullText_MUG

 

2021

Beyer, J; Collette, L; Sauvé, N; Daugaard, G; Feldman, DR; Tandstad, T; Tryakin, A; Stahl, O; Gonzalez-Billalabeitia, E; De, Giorgi, U; Culine, S; de, Wit, R; Hansen, AR; Bebek, M; Terbuch, A; Albany, C; Hentrich, M; Gietema, JA; Negaard, H; Huddart, RA; Lorch, A; Cafferty, FH; Heng, DYC; Sweeney, CJ; Winquist, E; Chovanec, M; Fankhauser, C; Stark, D; Grimison, P; Necchi, A; Tran, B; Heidenreich, A; Shamash, J; Sternberg, CN; Vaughn, DJ; Duran, I; Bokemeyer, C; Patrikidou, A; Cathomas, R; Assele, S; Gillessen, S, , International, Germ, Cell, Cancer, Classification, Update, Consortium Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.
J Clin Oncol. 2021; 39(14):1553-1562 Doi: 10.1200/JCO.20.03292 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Gillessen, S; Sauvé, N; Collette, L; Daugaard, G; de, Wit, R; Albany, C; Tryakin, A; Fizazi, K; Stahl, O; Gietema, JA; De, Giorgi, U; Cafferty, FH; Hansen, AR; Tandstad, T; Huddart, RA; Necchi, A; Sweeney, CJ; Garcia-Del-Muro, X; Heng, DYC; Lorch, A; Chovanec, M; Winquist, E; Grimison, P; Feldman, DR; Terbuch, A; Hentrich, M; Bokemeyer, C; Negaard, H; Fankhauser, C; Shamash, J; Vaughn, DJ; Sternberg, CN; Heidenreich, A; Beyer, J, , International, Germ, Cell, Cancer, Classification, Update, Consortium Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.
J Clin Oncol. 2021; 39(14):1563-1574 Doi: 10.1200/JCO.20.03296 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Keil, F; Hartl, M; Altorjai, G; Berghold, A; Riedl, R; Pecherstorfer, M; Mayrbaurl, B; De Vries, A; Schuster, J; Hackl, J; Fureder, T; Melchardt, T; Burian, M; Greil, R Docetaxel, cisplatin and 5-FU compared with docetaxel, cisplatin and cetuximab as induction chemotherapy in advanced squamous cell carcinoma of the head and neck: Results of a randomised phase II AGMT trial
EUR J CANCER. 2021; 151: 201-210. Doi: 10.1016/j.ejca.2021.03.051
Web of Science PubMed FullText FullText_MUG

 

Lőcsei, Z; Sebestyén, K; Sebestyén, Z; Fehér, E; Soltész, D; Musch, Z; Mangel, LC IMAT-IGRT Treatment with Simultaneous Integrated Boost as Dose Escalation for Patients with Cervical Cancer: A Single Institution, Prospective Pilot Study.
Pathol Oncol Res. 2021; 27: 608446 Doi: 10.3389/pore.2021.608446 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Magnes, T; Wagner, SM; Melchardt, T; Weiss, L; Rinnerthaler, G; Huemer, F; Kopp, M; Gampenrieder, SP; Mayrbäurl, B; Füreder, T; Lenger, D; Andel, J; Egle, A; Greil, R Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT.
Wien Klin Wochenschr. 2021; 133(21-22):1131-1136 Doi: 10.1007/s00508-021-01939-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Posch, F; Prinz, F; Balihodzic, A; Mayr, C; Kiesslich, T; Klec, C; Jonas, K; Barth, DA; Riedl, JM; Gerger, A; Pichler, M MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms.
Cancers (Basel). 2021; 13(16): Doi: 10.3390/cancers13163996 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Rouprêt, M; Babjuk, M; Burger, M; Capoun, O; Cohen, D; Compérat, EM; Cowan, NC; Dominguez-Escrig, JL; Gontero, P; Hugh Mostafid, A; Palou, J; Peyronnet, B; Seisen, T; Soukup, V; Sylvester, RJ; Rhijn, BWGV; Zigeuner, R; Shariat, SF European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.
Eur Urol. 2021; 79(1):62-79 Doi: 10.1016/j.eururo.2020.05.042 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Semrau, S; Gostian, AO; Traxdorf, M; Eckstein, M; Rutzner, S; von, der, Grün, J; Illmer, T; Hautmann, M; Klautke, G; Laban, S; Brunner, T; Tamaskovics, B; Frey, B; Zhou, JG; Geppert, CI; Hartmann, A; Balermpas, P; Budach, W; Gaipl, U; Iro, H; Fietkau, R; Hecht, M Implementation of Double Immune Checkpoint Blockade Increases Response Rate to Induction Chemotherapy in Head and Neck Cancer.
Cancers (Basel). 2021; 13(8): Doi: 10.3390/cancers13081959 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Thorne, LS; Rochford, G; Williams, TD; Southam, AD; Rodriguez-Blanco, G; Dunn, WB; Hodges, NJ Cytoglobin protects cancer cells from apoptosis by regulation of mitochondrial cardiolipin.
Sci Rep. 2021; 11(1): 985 Doi: 10.1038/s41598-020-79830-w [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2020

Fischer, S; Tandstad, T; Cohn-Cedermark, G; Thibault, C; Vincenzi, B; Klingbiel, D; Albany, C; Necchi, A; Terbuch, A; Lorch, A; Aparicio, J; Heidenreich, A; Hentrich, M; Wheater, M; Langberg, CW; Ståhl, O; Fankhauser, CD; Hamid, AA; Koutsoukos, K; Shamash, J; White, J; Bokemeyer, C; Beyer, J; Gillessen, S, , Global, Germ-Cell, Cancer, Group Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.
J Clin Oncol. 2020; 38(12):1322-1331 Doi: 10.1200/JCO.19.01876 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hecht, M; Gostian, AO; Eckstein, M; Rutzner, S; von, der, Grün, J; Illmer, T; Hautmann, MG; Klautke, G; Laban, S; Brunner, T; Hinke, A; Becker, I; Frey, B; Semrau, S; Geppert, CI; Hartmann, A; Balermpas, P; Budach, W; Gaipl, US; Iro, H; Fietkau, R Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8.
J Immunother Cancer. 2020; 8(2): Doi: 10.1136/jitc-2020-001378 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Klöckl, MC; Kasparek, AK; Riedl, JM; Moik, F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer, T; Schilcher, G; Zitta, S; Rosenkranz, AR; Friedl, C; Stöger, H; Posch, F Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
Sci Rep. 2020; 10(1):11219 Doi: 10.1038/s41598-020-68010-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Schmid, SC; Koll, FJ; Rödel, C; Maisch, P; Sauter, A; Beckert, F; Seitz, A; Kübler, H; Flentje, M; Chun, F; Combs, SE; Schiller, K; Gschwend, JE; Retz, M Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT).
BMC Cancer. 2020; 20(1): 8 Doi: 10.1186/s12885-019-6503-6 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Seidl, C; Panzitt, K; Bertsch, A; Brcic, L; Schein, S; Mack, M; Leithner, K; Prinz, F; Olschewski, H; Kornmueller, K; Hrzenjak, A MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2.
Cancer Lett. 2020; 469: 266-276. Doi: 10.1016/j.canlet.2019.10.044
Web of Science PubMed FullText FullText_MUG

 

2018

Dietz, A; Wichmann, G; Kuhnt, T; Pfreundner, L; Hagen, R; Scheich, M; Kölbl, O; Hautmann, MG; Strutz, J; Schreiber, F; Bockmühl, U; Schilling, V; Feyer, P; de Wit, M; Maschmeyer, G; Jungehülsing, M; Schroeder, U; Wollenberg, B; Sittel, C; Münter, M; Lenarz, T; Klussmann, JP; Guntinas-Lichius, O; Rudack, C; Eich, HT; Foerg, T; Preyer, S; Westhofen, M; Welkoborsky, HJ; Esser, D; Thurnher, D; Remmert, S; Sudhoff, H; Görner, M; Bünzel, J; Budach, V; Held, S; Knödler, M; Lordick, F; Wiegand, S; Vogel, K; Boehm, A; Flentje, M; Keilholz, U Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
Ann Oncol. 2018; 29(10): 2105-2114. Doi: 10.1093/annonc/mdy332 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Frille, A; Leithner, K; Olschewski, A; Olschewski, H; Wohlkönig, C; Hrzenjak, A No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
Int J Oncol. 2018; 52(2): 518-526. Doi: 10.3892/ijo.2017.4225 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Burgstaller, S; Fuchs, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Bartsch, R; Petru, E; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
BMC Cancer. 2018; 18(1):1074 Doi: 10.1186/s12885-018-4979-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Terbuch, A; Posch, F; Partl, R; Zurl, B; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.
Cancer Med. 2018; 7(2):508-514 Doi: 10.1002/cam4.1317 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Barac, A; Mitulovic, G; Hallström, S; Zehetmayer, S; Grasl, MC; Erovic, BM Impact of combined treatment with nimesulide and cisplatin on oral carcinoma cells.
Onco Targets Ther. 2017; 10(6):3607-3616 Doi: 10.2147/OTT.S131106 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Dulz, S; Asselborn, NH; Dieckmann, KP; Matthies, C; Wagner, W; Weidmann, J; Seidel, C; Oing, C; Berger, LA; Alsdorf, W; Mankichian, B; Meyer, C; Vetterlein, MW; Gild, P; Ludwig, TA; Soave, A; Schriefer, P; Becker, A; Ahyai, SA; Oechsle, K; Bokemeyer, C; Wagenfeld, L; Fisch, M; Hartmann, M; Chun, FK; Kluth, LA Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer.
J Cancer Res Clin Oncol. 2017; 143(7):1319-1325 Doi: 10.1007/s00432-017-2384-8
Web of Science PubMed FullText FullText_MUG

 

Enzenhofer, E; Kadletz, L; Stanisz, I; Kotowski, U; Seemann, R; Schmid, R; Thurnher, D; Heiduschka, G Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines.
Head Neck. 2017; 39(5):900-907 Doi: 10.1002/hed.24699
Web of Science PubMed FullText FullText_MUG

 

Fadejeva, I; Olschewski, H; Hrzenjak, A MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas.
Oncotarget. 2017; 8(70):115754-115773 Doi: 10.18632/oncotarget.22975 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ferrari, S; Bielack, SS; Smeland, S; Longhi, A; Egerer, G; Sundby Hall, K; Donati, D; Kevric, M; Brosjö, O; Comandone, A; Werner, M; Monge, O; Palmerini, E; Berdel, WE; Bjerkehagen, B; Paioli, A; Lorenzen, S; Eriksson, M; Gambarotti, M; Tunn, PU; Jebsen, NL; Cesari, M; von Kalle, T; Ferraresi, V; Schwarz, R; Bertulli, R; Kasparek, AK; Grignani, G; Krasniqi, F; Sorg, B; Hecker-Nolting, S; Picci, P; Reichardt, P EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.
Tumori. 2017; 104(1):30-36 Doi: 10.5301/tj.5000696
Web of Science PubMed FullText FullText_MUG

 

Katanić, J; Matić, S; Pferschy-Wenzig, EM; Kretschmer, N; Boroja, T; Mihailović, V; Stanković, V; Stanković, N; Mladenović, M; Stanić, S; Mihailović, M; Bauer, R Filipendula ulmaria extracts attenuate cisplatin-induced liver and kidney oxidative stress in rats: In vivo investigation and LC-MS analysis.
Food Chem Toxicol. 2017; 99(2):86-102 Doi: 10.1016/j.fct.2016.11.018
Web of Science PubMed FullText FullText_MUG

 

Kotowski, U; Heiduschka, G; Kadletz, L; Fahim, T; Seemann, R; Schmid, R; Schneider, S; Mitterbauer, A; Thurnher, D Effect of thymoquinone on head and neck squamous cell carcinoma cells in vitro: Synergism with radiation.
Oncol Lett. 2017; 14(1):1147-1151 Doi: 10.3892/ol.2017.6189 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kotowski, U; Kadletz, L; Schneider, S; Foki, E; Schmid, R; Seemann, R; Thurnher, D; Heiduschka, G 6-shogaol induces apoptosis and enhances radiosensitivity in head and neck squamous cell carcinoma cell lines.
Phytother Res. 2017; Doi: 10.1002/ptr.5982
Web of Science PubMed FullText FullText_MUG

 

Lill, C; Bachtiary, B; Selzer, E; Mittlboeck, M; Thurnher, D A 5‑year update of patients with HPV positive versus negative oropharyngeal cancer after radiochemotherapy in Austria.
Wien Klin Wochenschr. 2017; 129(11-12):398-403 Doi: 10.1007/s00508-017-1171-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Longhi, A; Bielack, SS; Grimer, R; Whelan, J; Windhager, R; Leithner, A; Gronchi, A; Biau, D; Jutte, P; Krieg, AH; Klenke, FM; Grignani, G; Donati, DM; Capanna, R; Casanova, J; Gerrand, C; Bisogno, G; Hecker-Nolting, S; De Lisa, M; D'Ambrosio, L; Willegger, M; Scoccianti, G; Ferrari, S Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.
Eur J Cancer. 2017; 74(1):9-16 Doi: 10.1016/j.ejca.2016.12.016 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mairinger, FD; Vollbrecht, C; Flom, E; Christoph, DC; Schmid, KW; Kollmeier, J; Popper, HH; Mairinger, T; Walter, RFH Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma.
Oncotarget. 2017; 8(23):37502-37510 Doi: 10.18632/oncotarget.16398 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Račkauskas, R; Zhou, D; Ūselis, S; Strupas, K; Herr, I; Schemmer, P Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteins.
Oncol Rep. 2017; 37(6):3660-3666 Doi: 10.3892/or.2017.5622 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Tiran, V; Lindenmann, J; Brcic, L; Heitzer, E; Stanzer, S; Tabrizi-Wizsy, NG; Stacher, E; Stoeger, H; Popper, HH; Balic, M; Dandachi, N Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition.
Sci Rep. 2017; 7(1):10040-10040 Doi: 10.1038/s41598-017-09929-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ugurel, S; Loquai, C; Terheyden, P; Schadendorf, D; Richtig, E; Utikal, J; Gutzmer, R; Rass, K; Sunderkotter, C; Stein, A; Fluck, M; Kaatz, M; Trefzer, U; Kahler, K; Stadler, R; Berking, C; Holler, C; Kerschke, L; Edler, L; Kopp-Schneider, A; Becker, JC Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial
ONCOTARGET. 2017; 8(44): 76029-76043. Doi: 10.18632/oncotarget.18635 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Brambilla, E; Le Teuff, G; Marguet, S; Lantuejoul, S; Dunant, A; Graziano, S; Pirker, R; Douillard, JY; Le Chevalier, T; Filipits, M; Rosell, R; Kratzke, R; Popper, H; Soria, JC; Shepherd, FA; Seymour, L; Tsao, MS Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer.
J CLIN ONCOL. 2016; 34(11): 1223-1230. Doi: 10.1200/JCO.2015.63.0970 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum